Member Info for ic152

Icecool. If the SP was 200p right now they could raise £100m with a 15-20% dilution and be good to accelerate the trials and pay of the CLN.

Also, the security could well mean more aggressive buying prices from BP.

To say the SP is irrelevant is just a load of rubbish!

Heading for CLN in shares so expecting drops from this SP. Hope it’s just a minor drop and a rabbit is pulled!

Now hit the magic £100K loss in AVCT. Next CLN will wipe off more. But at least we own the IP, right?

They need to sell to the highest bidder soon. The SP is only dropping each day and it’s time to get what we can and let BP progress the tech faster and for the benefit of patients everywhere.

I used to think there was a plan and a deal would be here soon enough but this is an Aim typical share.

It’s not bed wetting! That’s frankly immature. Huge paper losses all round and it is the board and CC that oversee this.

CLN in 4-weeks with more dilution than required again. A board in control of the business would not have let this happen.

Shoestring budget until year end affects progress of clinical programs. Do you not want progress?

There are numerous ways they could stimulate the SP.

Where are the comms on FDA regulation increasing lifetime levels of Dox and why? Just as an example.

How many BC patients have been dosed prior to the P1B, can they release any of this info?

They have released 3 x rns recently but always make out that news will be a long time away bar a conference next quarter. Even that is vague

Crowfoot, don’t forget the LFT saga.😂

BP have teams of researcher's looking at competitive and novel new drugs. They will have been aware of Avacta for years now. This will be from the preclinical stage but with a heightened awareness from the P1 stage results.

Just as they would with all of the other preclinical opportunities, some of which have sold for $B+ valuations.

P1B will be the real eye opener for any asset that shows any enhancement in efficacy and safety.

It’s dropped that today. Add in the last few weeks as well……..inevitable dilution for a few peanuts

We are not close to being fully funded. Perhaps $15M left, peanuts for what we are trying to achieve.

Oxygen, a lower Dx value would still be more beneficial than diluting at a ridiculous price. If they are hanging on for a few million more then the cost will be many multiples of this.

It’s disingenuous to say it takes time and SP dropping to the floor is unimportant. Of course investors know risks and this is AIM. But!! Zero comms and engagement to bolster the SP is shameful.

If deals are being worked on they cannot discuss but there are many other ways to assuage SH’s.

Almost always a lack of comms and heavily reducing SP are linked to bad news. It won’t be the science.

6103 info was hidden in a spotlight video as an example of appalling comms

Completely unraveling. My losses grow and expectation of a crap raise with limited funds at stupidly diluted rates.

They are just getting on with it is very true, it’s just doesn’t have anything to do with raising value and managing the business.

Too busy in labs and praising each other on the wonderful science.

It has already been brutal. The tech must be worth more than the MC though.

If the market knew something bad was occurring it would have shifted quicker. Not that there may not be a shocking raise.

Where the hell is the Dx sale?

utter ****** icecool. knowing the tech is superb and managing to fundraise and raise awareness are completely different. this is a **** show. and likely heavy dilution. even the cln’s are diluting more each time.

the whole everything will be fine routine and those of us with genuine and well founded concerns iare bedwetters is nauseatingly stupid.

the stock market is littered with amazing tech that fails on this basis

Definitely looks that way and has for a while now. It’s pathetic if so!

Bella, how do you see the audit playing out with the current information we have?

Appreciate your opinion.

I think post audit the results from P1B should be eye opening to the investment community

Are they executing though?

Silence is often bad, so I hope you are right Icecool. Last year at this time we had silence, so I am well and truly burnt.

Dx should have been sold and having an easy audit should have been childsplay. But it hasn’t been.

Anyone that knows the science/tech knows it’s worth a fortune but I am far from sure that Cc and the BoD are in control financially.

Massively underwater here, my fault of course, but there has been zero positive financial or business news since inception.

No doubt I’ll get abuse for this but leaving it this close to audit smacks of incompetence. I sincerely hope I’m wrong!!!

How do they find the next 12 months without major dilution? Will selling Dx cover this?

My God this board has turned into a pile of sxxx!

Used to be informed comments. Now half lives and LFT bullsxxx! Half life is completely irrelevant, its safety and efficacy that matter whether half life is 10 years or a minute.

It works and the finances are the limiting step. They get a deal before they need to raise it flies! If they don’t it’s diluted.

Timster, it definitely works but the snails pace of progress is killing us. Cash burn with little progress is the main enemy.

Apologies , meant Wearegroot.

Seems my posts have disappeared? This board…..